Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05609942 |
|---|---|
| Brief Title: | Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies (AZURE) |
| First Submitted : | November 2, 2022 |
| First Submitted that Met QC Criteria : | November 2, 2022 |
| First Posted : | November 8, 2022 |
| Last Update Submitted that Met QC Criteria : | April 1, 2024 |
| Last Update Posted : | April 2, 2024 |